Global

Cardinal Health (CAH) Raising Eyebrows Among Investors

Cardinal Health, Inc. (NYSE:CAH) is on our radar right now but there could still be some opportunities on the horizon. Now trading with a market value of 19.02B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. As the day-to-day narrative ebbs and flows for this company, it is more important than ever to step back and get a bird’s eye view of the fundamental reality under the surface of this story.

Cardinal Health, Inc. (NYSE:CAH) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For CAH, the company currently has 1.18 billion of cash on the books, which is offset by 935 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 41.94 billion in total assets, balanced by 35.23 billion in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Cardinal Health, Inc. (CAH) saw 1.11 billion in free cash flow last quarter, representing a quarterly net change in cash of -5.7 billion. Perhaps most importantly where cash movements are concerned, the company saw about 1.18 billion in net operating cash flow.



Cardinal Health, Inc. (NYSE:CAH) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 32.64 billion in total revenues. That represents a quarterly year/year change in revenues of 0.02 in sequential terms, the CAH saw sales decline by -0.01.

But what about the bottom line? After all, that’s what really matters in the end. Cardinal Health, Inc. (CAH) is intriguing when broken down to its core data. The cost of selling goods last quarter was 31.1 billion, yielding a gross basic income of 1.54 billion. For shareholders, given the total diluted outstanding shares of 318 million, this means overall earnings per share of 0.36. Note, this compares with a consensus analyst forecast of 1.14 in earnings per share for its next fiscal quarterly report.




Is Cardinal Health, Inc. (NYSE:CAH) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 5.51 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 11.06. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Cardinal Health, Inc..

Previous ArticleNext Article

Related Post

Chico’s FAS, Inc. (CHS) vs. L Brands, Inc. (... Chico's FAS, Inc. (NYSE:CHS) and L Brands, Inc. (NYSE:LB) are the two most active stocks in the Apparel Stores industry based on today’s trading volum...
HP Inc. (HPQ) Key Indicators And Emerging Themes HP Inc. (NYSE:HPQ) gained 0.75% in first day of the new month, going up from its prior closing price of $21.39 to $21.55. The price has been moving in...
UQM Technologies, Inc. (UQM) Just Flashed an Extre... UQM Technologies, Inc. (NYSE:UQM) gained 8.61% in yesterday’s session, going up from its prior closing price of $1.16 to $1.26, and has now recorded r...
Fundamentals in Focus for ImmunoGen, Inc. (IMGN) ImmunoGen, Inc. (NASDAQ:IMGN)'s interesting series of developments are underway around the US stock market these days. Now trading with a market value...
Does Achaogen, Inc. (AKAO) Present Much Upside ? Achaogen, Inc. (NASDAQ:AKAO) is one of the more popular stocks investors are adding into their watchlist. Now trading with a market value of 569.22M, ...